NYSEMKT:CANF
Can-Fite BioPharma Ltd Stock News
$1.94
-0.0300 (-1.52%)
At Close: Apr 24, 2024
Can-Fite Implements Interim Analysis for its Phase III Psoriasis Trial with Data Expected Q4 2020
11:00am, Monday, 30'th Mar 2020
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced t
Can-Fite Implements Interim Analysis for its Phase III Psoriasis Trial with Data Expected Q4 2020
12:00am, Monday, 30'th Mar 2020The Week In Cannabis: Marijuana Stocks Outperform S&P Again As Weed Is Deemed 'Essential' In COVID-19 Times
08:12pm, Saturday, 28'th Mar 2020
As the coronavirus (COVID-19) pandemic continues to spread, more and more states in the U.S. decide to declare cannabis an “essential” good, just like basic groceries...
Can-Fite Reports 2019 Financial Results & Provides Clinical Development Update
11:00am, Friday, 27'th Mar 2020
Can-Fite Reports 2019 Financial Results & Provides Clinical Development Update
Can-Fite Posts $9.6M Net Loss, Provides Clinical Trials Updates
12:00am, Friday, 27'th Mar 2020BMY, TLRY among premarket gainers
01:21pm, Monday, 23'rd Mar 2020
Waitr Holdings (NASDAQ:WTRH) +51% on expanding into Grocery Delivery.Innate Pharma S.A. (NASDAQ:IPHA) +34% on potential use of cancer drug for Covid-19.DCP Midstream, LP (NYSE:DCP) +31% on cutting
Can-Fite: Piclidenoson is Submitted for Compassionate Use Treatment for Coronavirus Patients in Israel
11:45am, Monday, 23'rd Mar 2020
Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced today
Can-Fite Submits its Piclidenoson for Compassionate Use Treatment for Coronavirus Patients in Israel
12:00am, Monday, 23'rd Mar 2020SLS, APRN among premarket gainers
01:23pm, Wednesday, 18'th Mar 2020
Biomerica (NASDAQ:BMRA) +133% on advancement of rapid coronavirus test.IMV (NASDAQ:IMV) +55% on coronavirus vaccine plan.Vaxart (NASDAQ:VXRT) +46% on coronavirus vaccine deal.Blue Apron Holdings (N
Can-Fite to Participate in Digital Bio-Europe Spring Partnering Conference; Looks to Partner on Co-Development for Coronavirus Treatment
Can-Fite: Progress in Compassionate Use Program Treating Advanced Liver Cancer Patients with Namodenoson
11:00am, Monday, 16'th Mar 2020
Can-Fite: Progress in Compassionate Use Program Treating Advanced Liver Cancer Patients with Namodenoson
The Week In Cannabis: Coronavirus Drop, Major Financing Agreements, Psychedelics Getting Hot
12:53pm, Saturday, 14'th Mar 2020
This was another brutal week for cannabis stocks, with all major ETFs posting double-digits losses. Over the last five trading days: The ETFMG Alternative Harvest ETF (NYSE: MJ ) lost 13.7%. The Advis
The Latest Coronavirus Developments From Biotechs: La Jolla Provides Giapreza In Italy, Enanta Researches Antivirals
02:53pm, Friday, 13'th Mar 2020
The following are the latest biotech announcements from late Thursday and Friday morning on the development of products targeting the coronavirus.
I-Mab ADR (NASDAQ: IMAB)...
